See more : GOLFZON Co., Ltd. (215000.KQ) Income Statement Analysis – Financial Results
Complete financial analysis of CBD of Denver Inc. (CBDD) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of CBD of Denver Inc., a leading company in the Specialty Retail industry within the Consumer Cyclical sector.
You may be interested
- Matrimony.com Limited (MATRIMONY.NS) Income Statement Analysis – Financial Results
- Goldgroup Mining Inc. (GGA.TO) Income Statement Analysis – Financial Results
- Mural Oncology plc (MURA) Income Statement Analysis – Financial Results
- Southern Cross Gold Ltd (SXG.AX) Income Statement Analysis – Financial Results
- Ares Capital Corporation (0HHP.L) Income Statement Analysis – Financial Results
CBD of Denver Inc. (CBDD)
About CBD of Denver Inc.
CBD of Denver Inc. engages in developing and commercializing cannabidiol (CBD) products. It is involved in the research, development, and distribution of premium hemp extract products. The company was formerly known as Verde Media Group, Inc. and changed its name to CBD of Denver Inc. in 2018. CBD of Denver Inc. is based in Centennial, Colorado. CBD of Denver Inc. operates as a subsidiary of Swiss Industry Ventures AG.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.98M | 2.34M | 22.85M | 16.00M | 25.08K | 0.00 | 0.00 | 0.00 | 5.04K | 42.50 |
| Cost of Revenue | 2.82M | 3.01M | 22.61M | 14.59M | 17.32K | 0.00 | 0.00 | 388.00 | 0.00 | 31.00 |
| Gross Profit | 165.48K | -669.60K | 240.52K | 1.41M | 7.76K | 0.00 | 0.00 | -388.00 | 5.04K | 11.50 |
| Gross Profit Ratio | 5.55% | -28.56% | 1.05% | 8.79% | 30.93% | 0.00% | 0.00% | 0.00% | 100.00% | 27.06% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 429.36K | 2.08M | 566.08K | 199.09K | 117.56K | 190.09K | 10.16K | 81.00K | 257.63K | 308.97 |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 429.36K | 2.08M | 566.08K | 199.09K | 117.56K | 190.09K | 10.16K | 81.00K | 257.63K | 308.97 |
| Cost & Expenses | 3.25M | 5.09M | 23.18M | 14.79M | 134.89K | 190.09K | 10.16K | 81.39K | 257.63K | 339.97 |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 205.85 |
| Interest Expense | 113.84K | 3.43K | 4.67K | 178.39K | 0.00 | 6.09K | 8.15K | 8.17K | 0.00 | 0.00 |
| Depreciation & Amortization | 167.90K | 228.49K | 236.56K | 2.58K | 171.86K | 161.14K | 52.52K | 388.00 | 0.00 | 1.54 |
| EBITDA | 697.77K | -3.25M | -299.98K | 1.21M | 291.15K | 603.13K | -10.16K | -81.00K | -252.58K | -295.93K |
| EBITDA Ratio | 23.40% | -117.20% | -1.42% | 7.57% | -437.87% | 0.00% | 0.00% | 0.00% | -5,007.53% | -696.30% |
| Operating Income | -263.89K | -2.75M | -325.56K | 1.21M | -109.81K | -190.09K | -10.16K | -81.39K | -252.58K | -297.47 |
| Operating Income Ratio | -8.85% | -117.20% | -1.42% | 7.55% | -437.87% | 0.00% | 0.00% | 0.00% | -5,007.53% | -699.92% |
| Total Other Income/Expenses | 847.81K | -510.21K | 20.92K | -178.39K | 400.96K | 787.13K | -8.14K | -8.17K | 0.00 | -205.85 |
| Income Before Tax | 583.92K | -3.26M | -304.64K | 1.03M | 291.15K | 597.04K | -18.30K | -89.56K | -252.58K | -503.32 |
| Income Before Tax Ratio | 19.58% | -138.97% | -1.33% | 6.43% | 1,160.98% | 0.00% | 0.00% | 0.00% | -5,007.55% | -1,184.28% |
| Income Tax Expense | 344.00 | -6.30K | -68.45K | 250.10K | -171.86K | -161.14K | -52.52K | 1.00 | 0.00 | 0.00 |
| Net Income | 583.58K | -3.25M | -236.19K | 779.14K | 291.15K | 597.04K | -18.30K | -89.56K | -252.58K | -503.32 |
| Net Income Ratio | 19.57% | -138.70% | -1.03% | 4.87% | 1,160.98% | 0.00% | 0.00% | 0.00% | -5,007.55% | -1,184.28% |
| EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Weighted Avg Shares Out | 6.38B | 5.70B | 5.25B | 4.65B | 3.91B | 3.90B | 3.90B | 3.90B | 3.90B | 472.16K |
| Weighted Avg Shares Out (Dil) | 16.70B | 5.70B | 5.25B | 19.85B | 14.26B | 3.90B | 3.90B | 3.90B | 3.90B | 471.91K |
CBD of Denver Announces Q3 Revenue and Updates on Spinoff and German Market
Q3 Financial Performance Denver, Colorado--(Newsfile Corp. - November 10, 2024) - CBD of Denver (OTC Pink: CBDD) is pleased to report estimated third quarter 2024 revenue of $763,450.00 compared to an estimated $677,893.00 for the same period in 2023. German...
CBD of Denver, Inc. Reports Financial Results for the Three and Six Months Ended June 30, 2024
Denver, Colorado--(Newsfile Corp. - August 30, 2024) - CBD of Denver, Inc. (OTC Pink: CBDD) today announced its unaudited financial results for the three and six months ended June 30, 2024. The Company continues to navigate challenging market conditions while...
CBD of Denver Announces Q2 Revenue and Provides Update on German Market
Denver, Colorado--(Newsfile Corp. - August 5, 2024) - CBD of Denver, Inc. (OTC Pink: CBDD) today announced that revenue for Q2 2024 is estimated to be approximately $1,030,000 compared to $720,000 for Q2 2023. Revenue from Libra 9 is not...
CBD of Denver Announces June Revenue and Successful Exhibition at Mary Jane Trade Fair in Berlin
Denver, Colorado--(Newsfile Corp. - July 1, 2024) - CBD of Denver, Inc. (OTC Pink: CBDD) today announced that revenue for June 2024 is estimated to be approximately $300,000 with the Company completing a successful exhibition at the Mary Jane trade...
CBD of Denver Inc. Announces Strong April and May Sales
Denver, Colorado--(Newsfile Corp. - June 6, 2024) - CBD of Denver, Inc. (OTC Pink: CBDD) today announced strong April revenue of approximately $490,000.00 USD, with approximately $420,000.00 USD coming from Luxora and approximately $70,000.00 USD coming from Libra 9. May...
CBD of Denver Inc. Announces Filing of Q1 Quarterly Disclosure and Financials
Denver, Colorado--(Newsfile Corp. - May 9, 2024) - CBD of Denver, Inc. (OTC Pink: CBDD) is pleased to announce the filing of its financial results for the quarter ended March 31, 2024. The Company successfully filed its quarterly report ahead...
CBD of Denver Inc. Announces Annual Disclosure and Filing of Financial Statements
Denver, Colorado--(Newsfile Corp. - May 2, 2024) - CBD of Denver, Inc. (OTC Pink: CBDD) has filed its financial results for the year ended December 31, 2023. The results highlight significant financial improvements and strategic achievements.
CBD of Denver Inc. Announces New Advisory Board Member for Luxora
Denver, Colorado--(Newsfile Corp. - April 12, 2024) - CBD of Denver, Inc. (OTC Pink: CBDD) today announced that John Barnet will be joining Luxora, Inc. as advisory board member. Luxora is delighted to announce the addition of John, a distinguished...
CBD of Denver Inc. Reports Q1 Revenue
Denver, Colorado--(Newsfile Corp. - April 9, 2024) - CBD of Denver, Inc. (OTC Pink: CBDD) today announced that its revenue for the first quarter of 2024 was approximately $1,116,300.00 USD. Of this, Libra 9 GmbH contributed approximately $175,600.00 USD, while...
CBD of Denver Inc. Reports January Revenue, Progress on Legislation in Germany and Business Highlights
Denver, Colorado--(Newsfile Corp. - February 12, 2024) - CBD of Denver, Inc. (OTC Pink: CBDD), today announced revenue for January 2024 was approximately $350,000.00 USD, with Libra 9 GmbH generating approximately $50,000.00 USD in revenue and Luxora generating approximately $300,000.00...
Source: https://incomestatements.info
Category: Stock Reports